Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klapper

Showing results (1061-1070 of 1,153) with videos related to

Pageof 116
Sort By:
Blood Neoplasia|June 2, 2025
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trialUlrich Dührsen, Andreas Bockisch, Bernd Hertenstein, et al.
Frontiers in Immunology|August 14, 2025
Engineered human B cells targeting tumor-associated antigens exhibit antigen presentation and antibody-mediated functionsAlexander Boucher, Courtney Anderson, Rochelle Hinman, et al.
Leukemia|August 30, 2023
Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphomaFranziska Briest, Daniel Noerenberg, Cornelius Hennch, et al.
Genome Medicine|May 2, 2019
A modular transcriptome map of mature B cell lymphomasHenry Loeffler-Wirth, Markus Kreuz, Lydia Hopp, et al.
International Journal of Cancer|June 12, 2013
Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological featuresAnna Enjuanes, Robert Albero, Guillem Clot, et al.
Haematologica|April 16, 2017
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker ConsortiumWendy B C Stevens, Matias Mendeville, Robert Redd, et al.
The New England Journal of Medicine|March 2, 2017
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic LeukemiaHagop Kantarjian, Anthony Stein, Nicola Gökbuget, et al.
Leukemia|August 16, 2024
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaborationFabian Frontzek, Loïc Renaud, Ulrich Dührsen, et al.
JAMA Oncology|January 2, 2025
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical TrialStephen Daw, Alexander Claviez, Lars Kurch, et al.
Genes, Chromosomes & Cancer|October 2, 2008
Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression statusCarsten Schwaenen, Andreas Viardot, Hilmar Berger, et al.
Pageof 116

Showing results (1061-1070 of 1,153) with videos related to

Sort By:
Pageof 116
Blood Neoplasia|June 2, 2025
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trialUlrich Dührsen, Andreas Bockisch, Bernd Hertenstein, et al.
Frontiers in Immunology|August 14, 2025
Engineered human B cells targeting tumor-associated antigens exhibit antigen presentation and antibody-mediated functionsAlexander Boucher, Courtney Anderson, Rochelle Hinman, et al.
Leukemia|August 30, 2023
Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphomaFranziska Briest, Daniel Noerenberg, Cornelius Hennch, et al.
Genome Medicine|May 2, 2019
A modular transcriptome map of mature B cell lymphomasHenry Loeffler-Wirth, Markus Kreuz, Lydia Hopp, et al.
International Journal of Cancer|June 12, 2013
Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological featuresAnna Enjuanes, Robert Albero, Guillem Clot, et al.
Haematologica|April 16, 2017
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker ConsortiumWendy B C Stevens, Matias Mendeville, Robert Redd, et al.
The New England Journal of Medicine|March 2, 2017
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic LeukemiaHagop Kantarjian, Anthony Stein, Nicola Gökbuget, et al.
Leukemia|August 16, 2024
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaborationFabian Frontzek, Loïc Renaud, Ulrich Dührsen, et al.
JAMA Oncology|January 2, 2025
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical TrialStephen Daw, Alexander Claviez, Lars Kurch, et al.
Genes, Chromosomes & Cancer|October 2, 2008
Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression statusCarsten Schwaenen, Andreas Viardot, Hilmar Berger, et al.
Pageof 116